Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, March 28, 2024 | Back issues
Courthouse News Service Courthouse News Service

Diabetic Supplements

A putative class action against GNC over labeling on diabetic supplements may continue, a federal court in California ruled. Consumers claim labels describing the product’s functions did not include a disclaimer required under the Federal Food, Drug and Cosmetics Act.

SAN FRANCISCO – A putative class action against GNC over labeling on diabetic supplements may continue, a federal court in California ruled. Consumers claim labels describing the product’s functions did not include a disclaimer required under the Federal Food, Drug and Cosmetics Act.

Categories / Consumers, Health

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...